Proteinuria and severe mixed dyslipidemia associated with a novel APOAV gene mutation

J Clin Lipidol. 2010 Jul-Aug;4(4):310-3. doi: 10.1016/j.jacl.2010.06.004. Epub 2010 Jul 7.

Authors

Handrean Soran¹, Valentine Charlton-Menys, Robert Hegele, Jian Wang, Emyr W Benbow, Ian Roberts, Grahame Wood, Paul Durrington

Affiliation

¹ Cardiovascular Research Group, School of Clinical & Laboratory Sciences, University of Manchester, Core Technology Facility (3(rd) Floor), 46 Grafton Street, Manchester M139NT, United Kingdom.

PMID: 21122665
DOI: 10.1016/j.jacl.2010.06.004

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Apolipoprotein A-V
Apolipoproteins A / genetics*
Dyslipidemias / diagnosis*
Dyslipidemias / genetics*
Heterozygote
Humans
Hyperlipoproteinemia Type III / diagnosis
Kidney / pathology
Male
Mutation
Obesity / diagnosis
Proteinuria / diagnosis*
Proteinuria / genetics
RNA Splicing
Triglycerides / blood

Substances

APOA5 protein, human
Apolipoprotein A-V
Apolipoproteins A
Triglycerides